Update on the diagnosis and management of Behçet’s disease

od Rokutanda, Ryo, Kishimoto, Mitsumasa, Okada, Masato
izdano v Open Access Rheumatol (2014)

Lupus Enteritis and Cystitis

od Kaneshita, Shunya, Kishimoto, Mitsumasa, Okada, Masato
izdano v Intern Med (2017)

Tocilizumab (TCZ) may be an effective treatment for poly-juvenile idiopathic arthritis (pJIA) as for rheumatoid arthritis (RA)

od Yamaguchi, Ken-ichi, Kishimoto, Mitsumasa, Okada, Masato
Izdano 2012

Mizoribine is as Effective as Methotrexate for the Treatment of Polymyalgia Rheumatica: A Retrospective Case Series Analysis

od SHIRAISHI, Kazushige, SUDA, Masei, ROKUTANDA, Ryo, KISHIMOTO, Mitsumasa, OKADA, Masato
izdano v Arch Rheumatol (2018)

Patient Preference for Treatment Mode of Biologics in Rheumatoid Arthritis: A 2020 Web-based Survey in Japan

od Kishimoto, Mitsumasa, Yamairi, Fumiko, Sato, Noriko, Kobayashi, Jun, Yamauchi, Saori, Iwasaki, Tomohisa
izdano v Rheumatol Ther (2021)

Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 tria...

od Wei, James Cheng-Chung, Kim, Tae-Hwan, Kishimoto, Mitsumasa, Ogusu, Naoki, Jeong, Haeyoun, Kobayashi, Shigeto
izdano v Ann Rheum Dis (2021)

The hospital educational environment and performance of residents in the General Medicine In-Training Examination: a multicenter study in Japan

od Shimizu, Taro, Tsugawa, Yusuke, Tanoue, Yusuke, Konishi, Ryota, Nishizaki, Yuji, Kishimoto, Mitsumasa, Shiojiri, Toshiaki, Tokuda, Yasuharu
Izdano 2013

The Diagnosis and Treatment of Adult Patients with SAPHO Syndrome: Controversies Revealed in a Multidisciplinary International Survey of Physicians

od Furer, Victoria, Kishimoto, Mitsumasa, Tsuji, Shigeyoshi, Taniguchi, Yoshinori, Ishihara, Yoko, Tomita, Tetsuya, Helliwell, Philip S., Elkayam, Ori
izdano v Rheumatol Ther (2020)

Low rates of biologic-free clinical disease activity index remission maintenance after biologic disease-modifying anti-rheumatic drug discontinuation while in remission in a Japane...

od Yoshida, Kazuki, Kishimoto, Mitsumasa, Radner, Helga, Matsui, Kazuo, Okada, Masato, Saeki, Yukihiko, Solomon, Daniel H., Tohma, Shigeto
izdano v Rheumatology (Oxford) (2016)

Reactive arthritis after COVID-19 infection

od Ono, Keisuke, Kishimoto, Mitsumasa, Shimasaki, Teppei, Uchida, Hiroko, Kurai, Daisuke, Deshpande, Gautam A, Komagata, Yoshinori, Kaname, Shinya
izdano v RMD Open (2020)

An observational study of tocilizumab and TNF-α inhibitor use in a Japanese community hospital: different remission rates, similar drug survival and safety

od Yoshida, Kazuki, Tokuda, Yasuharu, Oshikawa, Hideto, Utsunomiya, Masako, Kobayashi, Tatsuo, Kimura, Makiko, Deshpande, Gautam A., Matsui, Kazuo, Kishimoto, Mitsumasa
Izdano 2011

Response to 'Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study'

od Yoshida, Kazuki, Matsui, Kazuo, Nakano, Hiroto, Oshikawa, Hideto, Utsunomiya, Masako, Kobayashi, Tatsuo, Kimura, Makiko, Deshpande, Gautam A, Kishimoto, Mitsumasa
Izdano 2011

Ixekizumab efficacy and safety with and without concomitant conventional disease-modifying antirheumatic drugs (cDMARDs) in biologic DMARD (bDMARD)-naïve patients with active psori...

od Coates, Laura C, Kishimoto, Mitsumasa, Gottlieb, Alice, Shuler, Catherine L, Lin, Chen-Yen, Lee, Chin Hyok, Mease, Philip J
izdano v RMD Open (2017)

Clinical significance of monitoring hypothyroidism in patients with autoimmune rheumatic disease: a retrospective cohort study

od Fukui, Sho, Ikeda, Yukihiko, Kataoka, Yuko, Yanaoka, Haruyuuki, Tamaki, Hiromichi, Tsuda, Tokutarou, Kishimoto, Mitsumasa, Noto, Hiroshi, Ohde, Sachiko, Okada, Masato
izdano v Sci Rep (2021)

Biologic Discontinuations Studies: A Systematic Review of Methods

od Yoshida, Kazuki, Sung, Yoon-Kyoung, Kavanaugh, Arthur, Bae, Sang-Cheol, Weinblatt, Michael E., Kishimoto, Mitsumasa, Matsui, Kazuo, Tohma, Shigeto, Solomon, Daniel H.
izdano v Ann Rheum Dis (2013)

TNF Antagonist Responsiveness in a United States Rheumatoid Arthritis Cohort

od Greenberg, Jeffrey D., Kishimoto, Mitsumasa, Strand, Vibeke, Cohen, Stanley B., Olenginski, Thomas P, Harrington, Thomas, Kafka, Shelly P., Reed, George, Kremer, Joel M.
Izdano 2008

Ixekizumab improves patient-reported outcomes up to 52 weeks in bDMARD-naïve patients with active psoriatic arthritis (SPIRIT-P1)

od Gottlieb, Alice B, Strand, Vibeke, Kishimoto, Mitsumasa, Mease, Philip, Thaçi, Diamant, Birt, Julie, Lee, Chin H, Shuler, Catherine L, Lin, Chen-Yen, Gladman, Dafna D
izdano v Rheumatology (Oxford) (2018)

Use of Data from Multiple Registries in Studying Biologic Discontinuation: Challenges and Opportunities

od Yoshida, Kazuki, Radner, Helga, Kavanaugh, Arthur, Sung, Yoon-Kyoung, Bae, Sang-Cheol, Kishimoto, Mitsumasa, Matsui, Kazuo, Okada, Masato, Tohma, Shigeto, Weinblatt, Michael E., Solomon, Daniel H.
izdano v Clin Exp Rheumatol (2013)

The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet’s disease: indication of anti-TNFα monoclonal antibodies

od Hisamatsu, Tadakazu, Ueno, Fumiaki, Matsumoto, Takayuki, Kobayashi, Kiyonori, Koganei, Kazutaka, Kunisaki, Reiko, Hirai, Fumihito, Nagahori, Masakazu, Matsushita, Mitsunobu, Kobayashi, Kenji, Kishimoto, Mitsumasa, Takeno, Mitsuhiro, Tanaka, Masanori, Inoue, Nagamu, Hibi, Toshifumi
Izdano 2013

Elevating the role of carers in rheumatoid arthritis management in the Asia‐Pacific region

od Pile, Kevin, Norager, Rachel, Skillecorn, Matthias, Gibson, Kathryn A., Elderton, Sue, Favorito, Wendy, Li, Zhanguo, Mu, Rong, Nakahara, Hideko, Kishimoto, Mitsumasa, Hirata, Shintaro, Kaneko, Yuko, Lau, Chak‐Sing, Tam, Lai‐Shan, Chen, Yi‐Hsing, Chen, Pearly, Wahking, Bryan, Furtner, Daniel
izdano v Int J Rheum Dis (2020)